Englebienne & Associates (E&A) are experts and consultants in the biomedical sciences. Founded in 2001 in Belgium as an LLC, E&A is led by Dr. Patrick Englebienne, who brings over 10 years experience in consulting internationally with pharma and diagnostics industries.
Dr. Englebienne is a published expert in drug and diagnostics design with over 65 articles and 2 books in the scientific literature. He is also the author of several US and European patents. He is a member of the Editorial Board of various scientific journals and member of many learned societies.
E&A's laboratory facility contains state of the art equipment in colloid and polymer synthesis, UV-vis spectroscopy, automated clinical analysis, immunoassay and receptor-assay design, biomolecular interaction studies, analytical and preparative HPLC, LC and TLC, in vitro reagent formulation and bioinformatics.
Our services are based on specialized biosensor technologies that allow evaluation of biomolecular interactions in real time. These technologies rely on the use of materials that experience chromic transitions when the ligand or receptor attached to them interact with their binding counterpart.
Some Notes on Our Products and Services
Specific expertise in immunoassay technology allows our scientific team to propose reagents designed according to your specific requirements. These reagents can be made available as raw materials with technology transfer, or as ready to use bulk reagents. Reagents using our specific chromic transition tracers are available for high sensitivity assays.
We can also help in developing and validating new in vitro diagnostic projects or in stabilizing of your protein(s) in buffered solution.
Our expertise in colloidal metal and conducting polymer synthesis allows us to design specific synthetic processes for producing materials that meet a customer's specific needs. We produce stable composite materials synthesized according to a proprietary technology designed in E&A laboratories which offer improved optical and electrical properties.
Expertise in biomolecular recognition, cell signal transduction and in silico modelization allows our team to successfully complete specific drug discovery programmes.
Specific analytical services, including pharmacopoeial analysis, are based on our combined expertise in analytical technology, pharmacology and drug discovery.
Training in biomolecular interactions and immunoassay technologies can be delivered to a place selected by our customers, including their own premises.